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Crystal Structure and Mutational Analysis
of the Human CDK2 Kinase Complex
with Cell Cycle±Regulatory Protein CksHs1
Yves Bourne,*² Mark H. Watson,* Michael J. Hickey,* 1995). The crystal structure of the CDK2±cyclin A com-
plex has recently revealed the mechanism of Cdk activa-William Holmes,³ Warren Rocque,³ Steven I. Reed,*
and John A. Tainer* tion by cyclin binding. Specifically, cyclin-induced con-
formational changes in the PSTAIRE helix and the T loop*Department of Molecular Biology
Scripps Research Institute expose the catalytic cleft and CDK2 Thr-160 for CAK
phosphorylation (Jeffrey et al., 1995).10666 North Torrey Pines Road
La Jolla, California 92037 Besides both positive and negative regulation by
phosphorylation and binding of cyclins and Cdk-inhibi-³Glaxo±Wellcome
5 Moore Drive tory proteins, Cdks interact with a class of regulatory
proteins represented by Cks1 (Cdc28 kinase subunit) inResearch Triangle Park, North Carolina 27709
Saccharomyces cerevisiae (Hadwiger et al., 1989) and
suc1 (suppressor of cdc2 temperature-sensitive muta-
tions) in Schizosaccharomyces pombe (Hayles et al.,
Summary 1986a; Hindley et al., 1987). The yeast Cks proteins have
essential cell cycle functions, based on geneticanalysis.
The 2.6 AÊ crystal structure for human cyclin-depen- In addition, these proteins are phylogenetically con-
dent kinase 2 (CDK2) in complex with CksHs1, a human served at both the structural and functional levels, as
homolog of essential yeast cell cycle±regulatory pro- two human homologs, CksHs1 and CksHs2, functionally
teins suc1 and Cks1, reveals that CksHs1 binds via substitute for Cks1 in S. cerevisiae (Richardson et al.,
all four b strands to the kinase C-terminal lobe. This 1990). Although Cks proteins are essential for cell cycle
interface is biologically critical, based upon mutational progression in vivo, and have been shown both geneti-
analysis, but far from the CDK2 N-terminal lobe, cyclin, cally and in vitro to interact with Cdks (Brizuela et al.,
and regulatory phosphorylation sites. CDK2 binds the 1987; Hadwiger et al., 1989), their precise biological
Cks single domain conformation and interacts with function is an enduring mystery (Morgan, 1995; Endicott
conserved hydrophobic residues plus His-60 and Glu-
and Nurse,1995). Conflicting activities for Cks homologs
63 in their closed b-hinge motif conformation. The b
have been inferred from different genetic and biochemi-
hinge opening to form the Cks b-interchanged dimer cal experiments. The genetic approaches have included
sterically precludes CDK2 binding, providing a possi- gene disruption (Hayles et al., 1986b; Hindley et al.,
ble mechanism regulating CDK2±Cks interactions. 1987), overexpression (Hadwiger et al., 1989; Hayles et
One face of the complex exposes the sequence-con- al., 1986a, 1986b; Moreno et al., 1989), and analysis of
served phosphate-binding region on Cks and the ATP- temperature-sensitive mutants (Tang and Reed, 1993).
binding site on CDK2, suggesting that Cks may target Biochemically, suc1 was shown to inhibit Cdk dephos-
CDK2 to other phosphoproteins during the cell cycle. phorylation on Tyr-15 (Dunphy and Newport, 1989). The
X-ray structures of three of the Cks proteins (CksHs2
Introduction [Parge et al., 1993], suc1 [Endicott et al., 1995; Bourne
et al., 1995], and CksHs1 [Arvai et al., 1995a]) have been
Cell cycle progression is regulated by the activity of solved, but they have not revealed the nature of the Cdk-
cyclin-dependent kinases (Cdks), which consist of z34 binding interface. However, thesestructures identify two
kDa catalytic subunits associated with essential cyclin- distinct suc1 conformations: a single domain fold (Endi-
regulatory subunits (for recent reviews see Pines and cott et al., 1995) and a b-interchanged dimer (Bourne et
Hunter, 1991; Reed, 1992; Hunter, 1993; Dunphy, 1994; al., 1995). Similar dual conformations occur between the
Morgan, 1995). Cdk activity is controlled via regulatory CksHs1 single domain fold (Arvai et al., 1995a) and the
pathways acting through four biochemical mechanisms. b-interchanged CksHs2 dimer (Parge et al., 1993).
Cdk activation involves cyclin binding and the phos- Here we present the 2.6 AÊ resolution crystal structure
phorylation of a conserved threonine (residing between of human CDK2 in complex with the human cell cycle
residues 160 and 170 in most Cdk sequences) by the regulatory protein CksHs1. This structure reveals the
Cdk-activating kinase (CAK) (Solomon et al., 1993; Poon mode of CDK2 binding to CksHs1, suggests a possible
et al., 1993; Fesquet et al., 1993; Fisher and Morgan, mechanism of cooperativity and self-regulation of Cks
1994; reviewed by Solomon, 1994). Cdk inhibition in- proteins during the cell cycle, and implicates Cks as a
volves phosphorylation of a conserved threonine± targeting or match-making protein for Cdks and at least
tyrosine pair (Gould and Nurse, 1989) by at least two one other phosphoprotein.
protein kinases, Wee1(McGowan and Russell, 1993) and
Myt1 (Mueller et al., 1995) and binding of Cdk-inhibitory
Results and Discussionproteins (reviewed in Hunter and Pines, 1994; Morgan,
Structure Determination
The crystal structure of human CDK2 in complex with²Present address: Laboratoire de Cristallographie et de Cristallisa-
CksHs1 was determined by molecular replacement intion des MacromoleÂcules Biologiques, CentreNational de laRecher-
two different crystal forms that yielded identical com-che Scientifique, Institut de Recherche ConcerteÂ e 1, 31 Joseph
Aiguier, 13402 Marseille Cedex 20, France. plexes at low resolution. Monoclinic crystals with space
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group P21 (a 5 56.8 AÊ , b 5 69.9 AÊ , c 5 60.5 AÊ , and b 5 The localization of the CDK2 interface within the se-
quence-continuous region Asp-206 to Trp-243 suggests114.58), which contain one CDK2±CksHs1 complex per
asymmetric unit, were used to obtain the refined struc- that Cks binding is unlikely to trigger any global CDK2
conformational change, which is consistent with the ob-ture, since they gave higher resolution diffraction than
the orthorhombic crystals also analyzed. The human served similarities of this novel CDK2 structure to ex-
isting Cdk structures (Cox et al., 1994; Goldsmith andCDK2±CksHs1 complex structure was refined at 2.6 AÊ
resolution to a crystallographic R value of 19.8% using Cobb, 1994) and with the noninhibitory effect of Cks
proteins on Cdk catalytic activity (Moreno et al., 1989;all reflections in the 6 AÊ ±2.6 AÊ resolution range with good
stereochemistry (see Experimental Procedures). The ex- Tang and Reed, 1993). In contrast with the sequence-
local CDK2 interface, the Cks interface involves regionscellent quality of the 2.6 AÊ electron density map unam-
biguously reveals the positions of the carbonyl oxygens throughout the entire sequence, with each b strand con-
tributing interface residues on one surface and phos-and side chains in CDK2 and CksHs1, as well as at the
complex interface (Figure 1A). phate anion±binding site residues (b1 Lys-11, b2 Arg-20,
b3 Trp-54, and b4 Arg-71) on the opposite solvent-ex-
posed face (Figures 1C and 1D).
Overall Structure of the Complex The complex interface extends over 25 AÊ in a direction
The structure of human CDK2 in complex with CksHs1 roughly parallel to the CksHs1 b3 and involves both
consists of an N-terminal lobe (N-lobe) (residues 1±85) hydrophobic and polar interactions. Hydrophobic inter-
and a large C-terminal lobe (C-lobe), with the ATP-bind- actions cluster within the CksHs1 b sheet at the center
ing site located in a cleft between the two lobes, as of the complex interface, with two discrete patches of
seen for free CDK2 (deBondt et al., 1993). This kinase polar interactions located at each extremity, which result
fold is conserved throughout the entire protein kinase in the formation of 17 hydrogen bonds involving three
family (Taylor and Radzio-Andzelm, 1994). CksHs1 is solvent molecules. The surface area at the complex in-
folded into four antiparallel b strands (b1 to b4) and two terface represents a total of 650 AÊ 2 buried to a 1.6 AÊ
short a helices, with overall dimensions of 35 AÊ 3 25 radius probe on each protein and is mainly hydrophobic
AÊ 3 35 AÊ . In sequence order, there is an N-terminal b (55%). The complex interface, which buries 14% of the
hairpin followed by an exposed a-helical hairpin, and total solvent-accessible CksHs1 surface area, involves
then a C-terminal b hairpin that results in a four-stranded 13 CDK2 side chain residues and 17 CksHs1 side chain
b sheet, which shows a surprising topological homology residues. A cluster of CksHs1 hydrophobic residues
with the N-lobe domain of CDK2 (Arvai et al., 1995a). (Tyr-12, Tyr-19, Met-23, Tyr-57, Met-58, Ile-66, and Leu-
CksHs1 interacts exclusively with the CDK2 C-lobe 68) plus two histidines (His-21 and His-60) pack closely
and is positioned at the opposite side relative to the to CDK2 hydrophobic residues (Ile-209 and Phe-213 in
structurally homologous CDK2 N-lobe (Figure 1B). This helix a5 and Phe-240, Pro-241, and Trp-243 in loop L14)
places CksHs1 over 26 AÊ from CDK2 Tyr-15, suggesting (Figures 2A and 2B). CDK2 Glu-208 and Ile-209 back-
that proposed interference with dephosphorylation of bone nitrogens form key charged hydrogen bonds to
CDC2 Tyr-15 in Cdk±Cks complexes (Hayles et al., CksHs1 Glu-63 side chain carboxylate, which also pro-
1986a; Dunphy and Newport, 1989; Jessus et al., 1990) vides remarkable charge complementarity for the posi-
is unlikely, but feasible. This CksHs1-binding site is also tively charged N-cap of CDK2 helix a5 (Figure 2C).
entirely distinct from the cyclin-binding site located pre-
dominantly in the CDK2 N-lobe from the CDK2±cyclin Structural Chemistry for Cdk±Cks
A complex crystal structure (Jeffrey et al., 1995). Binding Specificity
Compared with thealmost identical CksHs1 and CksHs2
homologs (81% identity), the two yeast homologs, suc1
The Human CDK2±CksHs1 Interface and Cks1, have extensions at both the N- and C-termini
CksHs1 binds to the CDK2 C-lobe using all four b and a nine residue insertion in the middle of the protein,
strands, the b1±b2 loop, and the b-hinge region to form resulting in an identity of only 53% (Richardson et al.,
a continuous saddle-shaped interface across CDK2 he- 1990) (Figure 3A). However, 15 out of the 17 residues
lix a5 and loop L14 (Figures 1C, 1D, and 2A). The con- responsible for the structural interactions in kinase bind-
cave interior face of the CksHs1 four-stranded b sheet ing identified here are invariant within the Cks protein
envelops the CDK2 helix a5 and the insert loop L14 family. Thus, the three-dimensional structure of CksHs1
of 25±30 residues located between helices a5 and a6.
Consequently, the CksHs1 b3±b4 loop, defined as the
b-hinge region (Bourne et al., 1995), points toward the
(Figure 1 legend continued)CDK2 active site cleft, whereas the b1±b2 loop is di-
rected into the solvent at the opposite side of the com- A CksHs1 Ca trace (orange) is shown through the surface and re-
plex interface (Figure 1C). The Cdk loop L14 is specific veals that the buried residues cluster in the interior concave face
of the CksHs1 b sheet and in the b1±b2 and b3±b4 loops, whichto Cdk protein kinases, but, curiously, is also found with
envelop the CDK2 helix a5 and loop L14 (green).weak homology in the mitogen-activated protein kinase,
(D) CDK2 molecular surface, with buried residues in helix a5 (green)the extracellular signal±regulated kinase 2 (Zhang et al.,
and loop L14 (cyan); nonburied residues are shown in white. CksHs11994), and the twitchin kinase (Hu et al., 1994; for review
residues involved in the binding interface are shown (orange bonds
see Goldsmith and Cobb, 1994), whereas L14 is absent with red oxygen, blue nitrogen, and yellow sulfur atoms as balls)
in the cAMP-dependent protein kinase (Knighton et al., with a Ca trace (yellow). CksHs1 residues in all four b strands partici-
pate in the binding interface.1991) and casein kinase I (Xu et al., 1995).
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Figure 1. Quality of the Structure and Overall View of the CDK2±CksHs1 Complex
(A) Stereo view of the 2.6 AÊ resolution omit Fo±Fc electron density map, contoured at 2s, showing the predominant cluster of hydrophobic
residues forming the binding interface. The coordinates of this region (5% of the total number of atoms) were omitted and the protein
coordinates were refined by simulated annealing before the phase calculation. Residues are labeled in white for CDK2 and in yellow for
CksHs1.
(B) Ribbon diagram of CksHs1 (yellow) bound to CDK2, with the N-lobe in purple and the C-lobe in blue and green. The ATP molecule is
displayed at the interface of the two CDK2 lobes (white bonds with red oxygen and blue nitrogen atoms as spheres) and is taken from the
free CDK2 coordinates (deBondt et al., 1993). The functional structural elements are color coded for CDK2: the b1±b2 loop, red; the disordered
loop to the PSTAIRE sequence in helix a1, asterisks; the T loop, white. Side chains forming the phosphorylation sites in the b1±b2 loop (Thr-
14 and Tyr-15) and in the T loop (Thr-160) (orange bonds with red oxygen atoms as balls), as well as the CksHs1 side chains forming the
conserved phosphate anion±binding site (b1 Lys-11, b2 Arg-20, b3 Trp-54, and b4 Arg-71) (white bonds with blue nitrogen atoms as balls),
are displayed. The CDK2 secondary elements involved in the binding interface are highlighted (green), and CksHs1 loops b1±b2 and b3±b4
are labeled L1 and L3, respectively.
(C) CksHs1 molecular surface, colored with the residues buried to a 1.6 AÊ probe radius in pale yellow, the nonburied residues in white, and
the phosphate anion±binding site in blue. A ribbon diagram of the CDK2 molecule is shown with the color code and orientation as in (B).
(Figure 1 legend continued on previous page)
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Figure 2. Interface of the CDK2±CksHs1
Complex
(A) Cross-section of the buried molecular sur-
face (purple for CDK2 and pale yellow for
CksHs1) at the CDK2±CksHs1 binding inter-
face viewed from CDK2 loop L14, showing
the continuous and complementary saddle-
shaped interface between CDK2 loop L14
and the interior concave face of the CksHs1
b sheet. Residues that participate in the bind-
ing interface are displayed for CksHs1 (or-
ange bonds with red oxygen, blue nitrogen,
and yellow sulfur atoms as balls), and mole-
cules are colored as in Figure 1B.
(B) Close-up stereo pair of the CDK2±CksHs1
complex interface, oriented roughly to match
Figure 1B and viewed from CDK2 helix a5,
with the molecules color coded as in (A). The
key complex interface side chains are dis-
played for CDK2 (purple bonds) and CksHs1
(orange bonds). The alignment of the CksHs1
Glu-63 side chain in the b-hinge region with
the direction of CDK2 helix a5 is shown (top).
Other polar interactions occur between CDK2
Ser-239 backbone carbonyl and CksHs1 Arg-
70 side chain, CDK2 Lys-242 backbone nitro-
gen and CksHs1 Asp-14 side chain, and
CDK2 Trp-243 side chain nitrogen and
CksHs1 Asp-13 carbonyl oxygen. An equiva-
lent cluster of polar interactions at the other
side of the interface occurs between CDK2
Asp-206 side chain and CksHs1 Tyr-7 hy-
droxyl and His-21 side chain, CDK2 Glu-208
side chain and CksHs1 His-60 side chain,
CDK2 Asp-210 side chain and CksHs1 His-
21 side chain, CDK2 Lys-237 side chain and
both the CksHs1 Ile-59 backbone carbonyl
and the Glu-61 side chain. Three ordered sol-
vent molecules (red spheres) are shownat the
binding interface. Two of them (top) establish
hydrogen bonds between CDK2 Lys-237 and
Asp-235 side chains and CksHs1 Glu-61
backbone nitrogen and side chain atoms and
between CDK2 Lys-237 side chain and
CksHs1 Tyr-57 carbonyl oxygen and Ile-59
backbone nitrogen atoms. The third one (bot-
tom) is hydrogen-bonded to CDK2 Ser-239
carbonyl oxygen and bothCksHs1 Tyr-19and
Arg-70 side chains.
(C) Stereo pair view of the refined sA-
weighting 2[Fo±Fc] electron density map
(contoured at 1s) of the CksHs1 b-hinge re-
gion in the closed conformation (residues
His-60 to His-65) and CDK2 helix a5, oriented
to match (A). The CksHs1 His-60 and Glu-
63 side chains within the b-hinge region are
hydrogen-bonded to residues in the N-cap of
CDK2 helix a5 (Glu-208 and Ile-209).
bound to CDK2 is expected to be representative of a place the single endogenous protein in yeast (Richard-
son et al., 1990).biologically important interaction conformation for both
human and yeast Cks proteins, and presumably all other The structure of the CDK2±CksHs1 complex suggests
the structural basis for Cks binding to the related CdkCks proteins. Furthermore, the Cdk residues involved
in the complex interface are invariant in both human protein kinase CDK3 (Meyerson et al., 1992) and the
lack of Cks binding to CDK4 or CDK5 (Azzi et al., 1994).and yeast kinases (Figure 3B), consistent with earlier
evidence that human Cks proteins can functionally re- Analysis of the amino acid sequences of these three
Crystal Structure of the CDK2±CksHs1 Complex
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protein kinases, which are representative members of
three different subfamilies within the Cdk family, re-
vealed a strict conservation of both the GDSEID motif
at the beginning of helix a5 and the (S,T)FPXW motif in
L14 for CDK3, but not for CDK4 or CDK5 (Figure 3B). In
fact, CDK4 lacks the L14 contact region entirely, ex-
plaining its lack of Cks binding. These results concerning
Cdk subfamily binding to Cks proteins support the im-
portance of the GDSEID and (S,T)FPXW kinase motifs




The ability of the Cks-conserved b-hinge motif HXPEPH
to switch between two distinct conformations may pro-
vide a structural mechanism for self-regulation of Cks
binding to Cdks. Closing of the b-hinge motif produces
the intrasubunit b hairpin and single domain fold, as
observed in unbound suc1 (Endicott et al., 1995) and
CksHs1 (Arvai et al., 1995a), as well as in this CDK2±
CksHs1 complex. Opening the b hinge to its extended
conformation may lead to the intersubunit b-strand in-
terchange and the interlocked dimer, as observed in
suc1 (Bourne et al., 1995) and CksHs2 (Parge et al.,
tified by closed circles. The only two variations in the Cdk-binding
region are found at position CksHs1 Met-58, which is glutamic acid
in both suc1 and Cks1, and at position CksHs1 Glu-61, which is
valine in suc1 and alanine in Cks1. The Met-58→Glu variation may
favor the formation of a hydrogen bond with the cdc2 kinase residue
Gln-224 in S. pombe and of a salt bridge with Cdc28 kinase residue
Arg-226 in S. cerevisiae without altering complex formation. In con-
trast, the Glu-61→Val(Ala) variation disrupts the unique salt bridge
formed between the CDK2-conserved Lys-237 and the glutamic
acid found in human Cks proteins, but likely has little influence on
the overall binding interface.
(B) The Cdk sequences are aligned for human CDK2, human CDC2,
S. pombe cdc2, S. cerevisiae Cdc28 (deBondt et al., 1993 and refer-
ences therein), and human CDK3 (Meyerson et al., 1992) in the two
regions that form the Cks-binding site (green), as well as for human
CDK4 (Khatib et al., 1993) and human CDK5 (Meyerson et al., 1992),
which do not bind Cks proteins. Both the nonconservation of the
GDSEID and (S,T)FPXW motifs and the lack of the insert region
between helices a5 and a6 characterize Cdks that are not regulated
by Cks proteins. Suc1-binding sites identified by alanine-scanning
mutagenesis of S. pombe cdc2 that match our structure are marked
(triangle), as well as the ts mutation Cdc28-1N (Pro-241→Leu) (as-
terisk).
(C) Ribbon model of the monomeric fold of CksHs1 monomer (yel-
low) bound to CDK2 (displayed as Ca trace except for helix a5 and
loop L14 and oriented to match Figure 1B, with the same color
Figure 3. Sequence Conservation and Cks Assembly code) with a superimposed CksHs2 interlocked dimer (pink and light
(A) The sequences of the two human homologs (CksHs1 and purple ribbons). The superimposition, which was done using the Ca
CksHs2) (Richardson et al., 1990) are aligned with those of the two atoms of one pair of folding domains (yellow for CksHs1 and light
yeast Cks proteins (S. pombe suc1 [Hayles et al., 1986a] and S. purple for CksHs2), reveals the strikingly different conformation of
cerevisiae Cks1 [Hadwiger et al., 1989]), with the residues involved the b-hinge region. The His-60 and Glu-63 side chains within the
in the complex formation (red) as well as those involved in the anion- b-hinge region are displayed in both Cks assemblies (orange bonds
binding site (blue) indicated. The b-hinge region His-60 to His-65 for monomeric CksHs1 and white bonds for b-interchanged dimeric
(red bar), which forms a b bend between b3 and b4 in CksHs1, is CksHs2) and reveal that the close vicinity of His-60 and Glu-63
sequence conserved, but is conformationally different in CksHs2, side chains, which requires the closed conformation of the b-hinge
where it forms an extended conformation promoting a b-strand region, is critical for CDK2 binding. Steric clashes occur between
exchange that interlocks two subunits into a dimer (Parge et al., the CDK2 N-lobe (purple Ca trace) and the adjacent subunit in the
1993). The position and identity of the four b strands and helices CksHs2 b-interchanged dimer structure (pink ribbon). Atoms are
are indicated beneath the sequence, and residues mutated are iden- color coded as in Figure 2A.
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1993). This b-hinge conformational switching could reg-
ulate Cdk binding, because it markedly alters the Cks
interface region in terms of its key residue accessibility,
steric compatibility, and side chain arrangements.
The CksHs1 single domain fold resulting from the
closed b-hinge conformation exposes at the b sheet
surface several conserved hydrophobic side chains
(Tyr-12, Tyr-17, Tyr-57, Met-58, Ile-66, and Leu-68) that
are crucial for the kinase interaction defined by our
structure. In contrast, the hexameric CksHs2 structure,
resulting from the open b-hinge conformation, seques-
ters these side chains within an internal channel (Parge
et al., 1993), preventing any access for kinase binding.
Similarly, the two suc1 crystal structures reveal that the
single domain fold exposes the same conserved hy-
drophobic residue cluster at the molecular surface as
in CksHs1 (Endicott et al., 1995), and the b-interchanged
dimeric fold sequesters this cluster within a cavity, as
in CksHs2 (Bourne et al., 1995).
Superimposition of the b-interchanged suc1 or
CksHs2 dimers with the single domain fold of CksHs1
bound to CDK2 reveals several steric clashes between
the CDK2 N-lobe and the adjacent subunit in the Cks
dimer, suggesting that the Cks b-interchanged dimer
fold cannot bind CDK2 (Figure 3C). Moreover, the critical
role played by CksHs1 His-60 and Glu-63 side chains
in the binding interface, located in the b-hinge region,
is apparently blocked by their different arrangement in
the extended conformation of the b-hinge HXPEPH motif
Figure 4. Binding Affinity Measurementsfound in the b-interchanged Cks structures (Figure 3C).
BIAcore binding data for the interaction of CDK2 with wild-typeThese observations are supported by gel filtration chro-
CksHs1 and mutants.
matography experiments on both the monomeric and (A) The resonance signal is plotted as a function of time for the
dimeric forms of suc1 in the presence of CDK2, which injection of 200 nM CDK2 over a sensor chip coupled with CksHs1
show noCDK2±suc1 complex formation with the b-inter- (1), CksHs1 Glu-63→Gln (2), CksHs1 Tyr-57→Ser, Met-58→Ala, His-
60→Asp, and Glu-63→Lys (3), and CksHs1 Tyr-12→Lys, Asp-changed dimeric form of suc1 (data not shown), and by
14→Lys, and Glu-15→Lys (4).similar results with BIAcore affinity measurements
(B) The resonance signal is plotted as a function of time for the(M. H. W. and S. I. R., unpublished data). Thus, the
injection of CDK2 at concentrations of 200 nM (1), 100 nM (2), 50
CDK2±CksHs1 complex structure reveals a potential nM (3), and 25 nM (4) over a sensor chip coupled with CksHs1. The
structural mechanism for self-regulation of Cks binding, injection period is indicated by a solid bar.
which could be triggered by alterations in the chemical
environment of the cell associated with cell cycle transi- cks1 ts-7 [Arg-104→Gln], cks1 ts-35 [Asp-37→Gly], cks1
tions (provided the b-interchanged dimer exists in vivo). ts-38 [Ser-36→Asp, Asn-39→Tyr], and cks1 ts-42 (Met-
46→Thr]) (Figure 3A; Tang and Reed, 1993). These ob-
servations suggest that Cdc28-1N is specifically defec-
Mutational Analysis of the CDK2±CksHs1 Interface tive in Cks1 interaction, accounting for its biological
The structure of the CDK2±CksHs1 complex suggests defect, and that, conversely, Cks1 mutants ts-3, ts-7,
biochemically and biologically important contact resi- ts-35, ts-38, and ts-42 might be defective in Cdk interac-
dues. A temperature-sensitive (ts) mutation in the S. tion. Consistent with the interpretation based on our
cerevisiae Cdk gene CDC28, cdc28-1N, substitutes the structure, the Cdc28 kinase isolated from the cdc28-1N
loop L14 Pro-250 to leucine (CDK2 residue 241). Based mutant is not temperature sensitive in vitro (Surana et
on our CDK2±CksHs1 complex structure, this mutation al., 1991), arguing against a defect in cyclin binding.
likely disrupts the tight cluster of aromatic residues lo- Likewise, Cdc28 kinase isolated from cks1 ts mutants
cated in the central region of the binding interface (CDK2 is not temperature sensitive, suggesting that interaction
Phe-213, Pro-241, and Trp-243 and CksHs1 Tyr-12, Tyr- between the two proteins involving CDK2 Pro-241
19, and Tyr-57), rather than interfering with cyclin bind- (Cdc28 Pro-250) is essential for cell cycle progression,
ing, as earlier proposed (Surana et al., 1991). The pheno- but not for an active kinase.
type conferred by this mutation is atypical for ts cdc28 To test further the biological importance of the struc-
mutations, as cells arrest predominantly in G2 rather ture-based model, we constructed three mutant alleles
than in G1. cks1 ts mutations confer a remarkably similar of CksHs1 intended to decrease interactions with CDK2.
phenotype, both in terms of cell cycle arrest (predomi- In the first, a single site charge change (Glu-63→Gln)
nantly in G2) and cell morphology. Interestingly, ts Cks1 removes the favorable glutamic acid carboxylate inter-
mutant proteins contain substitutions at positions im- actions with CDK2 Glu-208 and Ile-209 backbone nitro-
gens. A second mutant with more extensive changesportant for Cdk binding (e.g., cks1 ts-3 [Met-46→Arg],
Crystal Structure of the CDK2±CksHs1 Complex
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Table 1. CDK2±CksHs1 Estimated Equilibrium Dissociation Constant and Rate Constants
CksHs1 Ligand Kd (M) kon (M21s21) koff (s21)
Wild type 7.7 3 1028 3.2 3 105 2.5 3 1022
Tyr-12→Lys, Asp-14→Lys, Glu-15→ Lys UD UD UD
Glu-63→Gln UD UD UD
Tyr-57→Ser, Met-58→Ala, His-60→Asp, Glu-63→Lys UD UD UD
The numbers presented are mean values, and the uncertainties from the fitting procedures were less than 10% of the values. UD indicates
that the level of CDK2 binding was below that required for calculation of rate constants. All kinetics experiments were done in triplicate.
had four interface substitutions, Tyr-57→Ser, Met- type, Glu-63 mutationsapparently do not cause the non-
functional biological phenotype by structural alterations58→Ala, His-60→Asp, and Glu-63→Lys. In the third, Cks
residues Tyr-12, Asp-14, and Glu-15 were modified to (M. H. W., Y. B., A. S. Arvai, J. A. T., and S. I. R., unpub-
lished data). Taken together, these results suggest thatlysine to disrupt both hydrophobic and polar interac-
tions of CksHs1 with CDK2. The affinities of wild-type binding to Cdks is a critical function of Cks proteins and
that the CDK2±CksHs1 interface identified here repre-and mutant CksHs1 for CDK2 were measured in two
ways. First, a dissociation constant (Kd) was determined sents a biologically important interaction.
Previously, experiments on S. pombe cdc2 kinaseusing the BIAcore surface plasmon resonance detection
system. The Kd for wild-type CksHs1 was determined have attempted to locate the suc1-binding site by exten-
sive alanine-scanning mutagenesis (Ducommun et al.,by titrating CDK2 against a fixed amount of immobilized
CksHs1 and measuring the interaction (Figure 4). The 1991; Marcote et al., 1993). These studies suggested
that the suc1-binding site involved both the N- andKd for wild-type CksHs1 was 7.7 3 1028 M, consistent
with isothermal calorimeter experiments (data not C-lobes of cdc2, although removal of the L14 insert
between cdc2 helices a5 and a6 dramatically alteredshown), whereas for Glu-63→Gln, the level of binding
detected (Figure 4A) was too low to calculate a Kd. For suc1 binding (Ducommun et al., 1991). Our structure
shows that most of the sites implicated by cdc2 muta-both of the multiple mutations (Tyr-12→Lys, Asp-
14→Lys, and Glu-15→Lys and Tyr-57→Ser, Met- genesis do not lie in the interface and therefore, when
mutated, probably affect Cks binding indirectly. Only the58→Ala, His-60→Asp, and Glu-63→Lys) no binding was
detectable (Table 1). Thus, all of the mutant proteins Arg-214→Ala and Arg-217→Ala mutations in the CDK2
C-lobe, which eliminate suc1 binding without alteringwere defective in binding CDK2 in vitro. Next, we mea-
sured the in vivo binding of mutant and wild-type the kinase activity, are consistent with the interface re-
gion revealed by the CDK2±CksHs1 complex structure.CksHs1 to the endogenous Cdk of budding yeast,
Cdc28, which has all Cks contact residues conserved, The CDK2 Arg-217 stacks against the side chains of
CDK2 Trp-243 and CksHs1 Tyr-12, two key residues atusing the yeast two-hybrid system (Table 2). All three
mutant alleles were, again, strongly defective in inter- the complex interface. The Arg-214 side chain is not
directly involved in CksHs1 binding, but it stabilizes theacting with Cdc28, as predicted. Conversely, we used
the two-hybrid system to measure the affinity of ts mu- conformation of the two aspartate residues, Asp-206
and Asp-210, within the GDSEID motif. Thus, most oftant Cdc28-1N (Pro-250→Leu) for Cks1. Compared with
wild-type Cdc28, Cdc28-1N indeed showed severely re- the contact sites implicated by the alanine-scanning
mutagenesis results may reflect complex, indirect ef-duced binding to Cks1 (Table 2). The similar expression
of all of these two-hybrid fusion proteins was confirmed fects within the two-domain kinase structure.
by Western blotting, supporting the relevance of the
observed reduced binding. Finally, we tested the biolog- Exposed Sequence-Conserved Residues
Not Involved in Cdk Bindingical consequences of the three Cdk binding±defective
mutant alleles of CksHs1 and found them incapable of Besides the cluster of exposed conserved hydrophobic
residues forming the contact with Cdk, the Cks proteinsreplacing the endogenous gene in yeast (Table 2). Be-
cause the Glu-63→Gln-substituted structure of the ho- have a conserved and highly positive pocket of residues
(CksHs1 Lys-11, Arg-20, Trp-54, and Arg-71) that formsmologous human protein CksHs2 is identical to wild
Table 2. b-Galactosidase Activities of CDC28/Cks in the Two-Hybrid Assay and In Vivo Rescue of cks1 Disruption by CksHs1 Mutants
DNA-Binding Domain Fusion (%)a
Rescue of
Activation Domain Fusion Cdc28 Cdc28-1N cks1 Disruptionb
Cks1
Wild type 100 4.5 6 1.8
CksHs1
Wild type 100 1
Tyr-12→Lys, Asp-14→Lys, Glu-15→Lys 9.2 6 1.1 2
Glu-63→Gln 16.2 6 4.3 2
Tyr-57→Ser, Met-58→Ala, His-60→Asp, Glu-63→Lys 3.7 6 0.9 2
a The b-galactosidase activities represent the mean and standard deviation of four independent experiments each and are expressed as a
percentage of the activity of the wild-type protein.
b The CksHs1 proteins were assayed for their ability to rescue the cks1 disruption as described in Experimental Procedures.
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a phosphate anion±binding site exposed on the other
side of the molecule relative to the complex interface,
based upon structures of phosphate and the phosphate
analog vanadate bound to CksHs1 (Arvai et al., 1995a).
This result does not support the hypothesis of Cks bind-
ing to the CDK2 Thr-160 phosphate group or of Cks
oligomerization of Cdks (Parge et al., 1993). Thus, the
interlocked dimeric (or hexameric) form of Cks proteins
may represent a negative regulation of Cdk±Cks interac-
tion or a distinct non-Cdk-related function for Cks pro-
teins. Such a hypothesis of two distinct functions for
the Cks proteinshas been independently proposed (Jes-
sus et al., 1990). Our CDK2±CksHs1 structure positions
the Cks phosphate anion±binding site on the same side
of the Cdk catalytic site, in a cleft between the two lobes,
thus forming an extended recognition surface flanking
the CDK2 catalyticsite (Figures 1B and 5). Also, exposed
in the groove adjacent to the phosphate anion±binding
site, conserved Cks residues (Ile-6, Tyr-8, Glu-18, Pro-
25, Gln-50, and Ser-51) expand the conserved, exposed
surface that could participate in Cks binding to a second
protein. This suggests that Cks proteins act in targeting
Cdks to substrates or other phosphorylated proteins.
The CDK2±Cyclin A±CksHs1 Ternary Complex
Superimposition of CDK2 bound to CksHs1 with the
CDK2±cyclin A complex (Jeffrey et al., 1995) generates
a model for the ternary Cdk macromolecular assembly
(Figure 5). This model shows that the two binding sites
are distinct from each other and suggests that a ternary
complex can form within the cell, a result observed in
solution (data not shown). The model reveals a bowl-
shaped groove 20 AÊ in diameter, limited on each side
by the cyclin A and CksHs1 molecules, and positions
the CDK2 Thr-160 residue at the bottom center of the
groove. This groove is bordered by three lysine residues
of CksHs1 (Lys-26, Lys-30, and Lys-34) and two of cyclin
Figure 5. The CDK2±Cyclin A±CksHs1 Ternary Complex
A (Lys-226 and Lys-417), all pointing toward the CDK2
(A) Ribbon diagram of a CDK2±cyclin A±CksHs1 complex modelactive site cleft (Figure 5A). In addition, CksHs1 Pro-62
based on the coordinates of our CDK2±CksHs1 complex and those
is located only 7.5 AÊ away from CDK2 Thr-160 and faces of a CDK2±cyclin A complex (Jeffrey et al., 1995) in which the two
the cyclin A loop 269±272, also z8 AÊ away from CDK2 CDK2 molecules were superimposed based on the Ca atoms of the
C-lobe. Besides two distinct binding sites for cyclin A and CksHs1Thr-160. Thus, Cks binding could possibly restrict ac-
at the molecular surface of CDK2, this model reveals a large bowl-cess of CAK, the Cdk that phosphorylates Thr-160,
shaped groove centered around the phosphorylation site at Thr-which is likely tohave dimensions similar to CDK2 (about
160 (middle) in the activated conformation of the CDK2 T loop and
65 AÊ 3 45 AÊ 3 25 AÊ ); thus, within the cell there may be an bordered by cyclin A and CksHs1 molecules. The presence of posi-
obligatory order of events in which Cdk phosphorylation tively charged residues (Lys-24, Lys-30, and Lys-34 in CksHs1 and
precedes Cks binding. Similarly, Cks binding could po- Lys-226 and Lys-417 in cyclin A) located on each side of the groove
is displayed (purple bonds and blue for nitrogen atoms as balls).tentially interfere with the Cdk-associated phosphatase
The molecules and the functionally important elements in CDK2 areKAP, which dephosphorylates CDK2 Thr-160 when
color coded as in Figure 1B, with cyclin A in green. ATP is takencyclin is degraded (Poon and Hunter, 1995).
from the CDK2±cyclin A complex coordinates previously described
(Jeffrey et al., 1995).
Structural Changes in CDK2 and CksHs1 (B) Molecular surface of the CDK2±cyclin A±CksHs1 complex ori-
ented z908 away from that in (A), with the same color code. Theupon Binding
CksHs1 phosphate anion±binding site (blue) is exposed into theFree CDK2 resembles that bound to CksHs1 except for
solvent and located on the same side of the CDK2 catalytic sitesmall domain movements (root-mean-square deviation
with the ATP molecule bound between the two lobes, thus forming
[rmsd] of 0.9 AÊ for 279 Ca atoms and 0.59 AÊ for 204 Ca a continuous surface for recognition of a Cdk substrate or other
atoms of the CDK2 C-lobe). The largest differences (up phosphoproteins. The two CksHs1 a helices (orange) are also sol-
vent accessible. The T loop (white), containing the phosphorylation
site at position Thr-160 (middle), protrudes at the interface of
CksHs1 and cyclin A. Figures 1B±1D, 2A and 2B, 3C, and 4 were
generated with the Application Visualization System (AVS) (Ad-lau, 1989). The solvent-accessible surfaces were calculated with
vanced Visual Systems, Waltham, Massachusetts), and Figures 1AMS (Connolly, 1983), and the ribbon diagrams were generated using
and 2C were generated with TURBO-FRODO (Roussel and Cambil-RIBBONS (Carson, 1991) implemented in AVS.
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to 3 AÊ ) occur in the N-termini (residues 1±9) and in the enhancing the interaction. Second, the higher affinity of
Cks proteins for active kinase might restrict the pro-loops connecting the N-lobe b strands, but they appar-
ently reflect the domain flexibility previously seen for posed targeting function of Cks proteins to kinase mole-
cules capable of phosphorylating substrates. Such tar-the protein kinase family (Goldsmith and Cobb, 1994)
rather than the effect of Cks binding. Our structure also geting functions may direct the active kinase to
substrates or other regulatory proteins. With the natureshows an N-lobe conformational change of CDK2 resi-
dues 36±39 compared with free CDK2, which adopt a of the Cks±Cdk interaction defined, the role of Cks in
such Cdk substrate recognition and targeting processesconformation similar to that of the activated CDK2
bound to cyclin A (Jeffrey et al., 1995). In our CDK2± and in cell cycle progression can be tested by combined
genetic and biochemical studies.CksHs1 complex structure, the Leu-37 side chain points
toward a hydrophobic cluster (Ile-37, Ile-49, Leu-76, and
Phe-152), whereas Leu-37 points in an opposite direc- Experimental Procedures
tion in free CDK2. However, the remaining residues pre-
Site-Directed Mutagenesisceding the PSTAIRE sequence in the N-lobe and the T
Specific amino acid changes were introduced into the humanloop residues in the C-lobe are disordered in our crystal
CKSHS1 gene, contained in the bacterial expression plasmidstructure in the absence of cyclin (Figure 1B), as in the pRK171 (Rosenberg et al., 1987), using the Transformer mutagene-
free CDK2 structure (deBondt et al., 1993). Similarly, no sis kit (Clontech Laboratories) as described by the manufacturer.
major changes are seen in the bound Cks conformation. The mutagenic primers were as follows: Y12KD14KE15K, 59-cgatact
caaactcctttttgtcttttttgtccgaatag-39; Y57SM58AH60DE63K, 59-gcaaThus, any allosteric effects on either CDK2 or Cks from
gatgtgaggttttggttcatcgatcgcagaatggacccatccc-39; E63Q, 59-gcaagCDK2 binding would be subtle, if they occurred at all.
atgtgaggttgtggttcatgg-39. The mutant CKSHS1 sequences wereAlthough CksHs1 binding to CDK2 does not induce
amplified by PCR using flanking oligonucleotides containing BamHIdramatic conformational changes, some local changes
restriction sites, and the products were cloned into the yeast galac-
occur at the binding interface. A rigid-body motion is tose-inducible plasmid YCpG2 (Richardson et al., 1990) and the two-
observed for CDK2 residues 219±251, located in L14 hybrid GAL4 transcriptional activation domain plasmid pACT2. The
resulting constructs were confirmed by DNA sequencing, and mu-and helix a5. The largest deviations (up to 2 AÊ ) occur
tant CksHs1 proteins were purified as previously described for theat position Ser-239 and appear to be related to CDK2
wild-type protein (Arvai et al., 1995b).rearrangements upon CksHs1 binding. Similarly, the
most significant CksHs1 change occurs at the tip of
Two-Hybrid Assaysloop b3±b4, which shifts by 2.5 AÊ ±3 AÊ within the CDK2
CKSHS1 wild-type and mutants and S. cerevisiae CKS1 were cloned
binding site (an rmsd of 0.85 AÊ for 69 Ca atoms). into the BamHI restriction site in the polylinker of the plasmid pACT2
to yield GAL4 transcriptional activation domain fusion constructs
tagged with the hemagglutinin (HA) epitope and carrying the LEU2
gene. S. cerevisiae CDC28 and cdc28-1N open reading frames wereSignificance and Implications
cloned into the BamHI restriction site in the polylinker of the plasmidThe 2.6 AÊ resolution structure of the CDK2±CksHs1 com-
pAS1 (Durfee et al., 1993) to produce a GAL4 DNA-binding domainplex defines the interface region as confined to the Cdk
fusion construct tagged with the HA epitope and carrying the TRP1sequence±adjacent C-lobe helix a5 and loop L14. This
gene. The pACT2 constructs were transformed into the haploid S.
interface, confirmed by mutagenesis as critical for bio- cerevisiae strain Y190 (MATa gal4 gal80 his3 trp1-901 ade2-101
chemical and biological Cks±Cdk interactions, isconsis- ura3-52 leu2-3,1121 URA3::GAL→lacZ, LYS2::GAL(UAS)→HIS3-
cyhr) and selected on plates lacking leucine. The pAS1 constructstent with the observation that Cks association with Cdks
were transformed into the haploid strain Y187 (MATa gal4 gal80is not known to block the binding of any other protein
his3 trp1-901 ade2-101 ura3-52 leu2-3,112 met2URA3::GAL→lacZ)to Cdks.Structural changes are localized to the interface
and selected on plates lacking tryptophan. Yeast transformationsregion on both molecules, indicating that Cks proteins
were performed as described by Elble (1992). The expression of the
are not likely to function in Cdk regulation by inducing fusion proteins was confirmed by Western blotting using a mono-
a conformational change in the kinase. Rather, Cks pro- clonal antibody (12CA5) to the HA epitope.
Yeast cells (haploid or diploid) containing both pAS1-CDC28 andteins present one conserved region to the Cdk interface,
pACT2-CKSHS1 are not viable, making it impossible to maintainleaving the second sequence-conserved region ex-
strains containing both plasmids (M. H. W. and S. I. R., unpublishedposed and continuous with the CDK2 active site face.
data). Therefore, the method of ªquantitative matingº was used toCks binding, therefore, provides a sequence-conserved
measure the interaction betweenthe fusionproteins in newly formed
phosphate-binding region that forms an expanded rec- zygotes produced from mating haploid cells containing the individ-
ognition surface for the CDK2 catalytic site. ual plasmids. Y187 cells (5 3 107) containing the pAS1-CDC28 con-
struct were vacuum filtered onto 0.45 mm Metricel membranes (Gel-Our structure thus implicates Cks as acting in tar-
man Sciences). Y190 cells (5 3 107) carrying the pACT2-CKSHS1geting the Cdk to other proteins or macromolecular as-
constructs were filtered over the layer of Y187 cells, and the filtersemblies. However, the relatively moderate affinity of
was then placed onto a YEPD plate containing 1 M sorbitol with theCksHs1 for inactive Cdk2 as determined by biophysical
cell side up and incubated at 308C. After 5 hr, the filter was placed
methods (Kd 5 7.7 3 1028 M) allows for the possibility that into a 50 ml conical tube with 10 ml of YEPD media and vortexed
complexes with activated Cdks could be more favored in to resuspend the cells. The filter was discarded, and a sample of
the cells was fixed in formaldehyde for microscopic scoring of thevivo. This, coupled with the observation that CAK would
percentage of zygotes. The mating efficiency typically ranged be-be sterically prevented from phosphorylating Thr-160
tween 10% and 20%. The same procedure was performed to mea-on Cks-bound CDK2, leads to a hypothesis for complex
sure the interaction between pAS1-CDC28 or pAS1-cdc28-1N withformation and Cdk function. First, cyclin association
pACT2-CKS1. The cells were pelleted by a 10 min spin at 1000 rpm
would promote phosphorylation of the Cdk by CAK (Jef- in a clinical centrifuge. Extracts were prepared by resuspending the
frey et al., 1995). Cyclin binding and phosphorylation of pellets in 150 ml of 100 mM Tris±HCl (pH 8), 20% glycerol (v/v), 1
mM b-mercaptoethanol, 1 mg/ml leupeptin, 1 mM PMSF, 1 mg/mlCdk might place the T loop in contact with Cks, thereby
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pepstatin A, and 2 mg/ml aprotinin. Glass beads (0.5 mm diameter) complex was prepared by mixing CDK2 and CksHs1 in a 1:2 ratio,
followed by incubation for 30 min at 48C and then by gel filtrationwere added to the level of the meniscus and vortexed five times for
30 s, with 30 s intermissions on ice. Extracts were clarified by a 15 chromatography on a Sephacryl S100 column (Pharmacia) equili-
brated with 10 mM HEPES (pH 7.4), 150 mM NaCl, 5% glycerol, 1min spin at 14,000 3 g and then frozen in liquid nitrogen and stored
at 2708C. Protein concentrations were measured using the Bradford mM EDTA, and 1 mM DTT. The CDK2±CksHs1 fractions, which were
found at an apparent molecular mass of 44 kDa (corresponding toassay (Bradford, 1976). b-Galactosidase activity was measured us-
ing a chemiluminescent assay with the Galacto-Light Plus system a 1:1 complex, consistent with cross-linking experiments between
cdc2 and suc1 [Ducommun et al., 1991]), were analyzed by 12%(Tropix) following the procedure suggested by the manufacturer. In
brief, 5±20 ml of extract was added to 100 ml of diluted Galacton SDS±polyacrylamide gel electrophoresis, concentrated to 15±20
mg/ml under nitrogen using an Amicon concentrator with a 10 kDaand incubated at room temperature for 30 min. We added 100 ml
of accelerator solution and measured chemiluminescence in dupli- membrane cutoff, and stored at 2708C.
Crystals were obtained by the vapor diffusion technique at 208Ccate for 5 s using a Lumat LB9501 luminometer. The chemilumines-
cent signal was normalized for the amount of protein and the after mixing an equal volume of the complex with the well solution
containing 17%±19% polyethylene glycol monomethyl esterpercentage of zygotes and expressed as a percentage of
b-galactosidase activity relative to wild-type CksHs1. We performed (MEPEG) 5K, 100 mM Tris (pH 7.5), and 100 mM KCl. Crystals grew
within 1 day, and two different crystal forms, here termed A and B,three to five independent matings for each experiment.
were frequently observed in the same drop. Form A crystals belong
to the orthorhombic space group P212121 with cell dimensions a 5In Vivo Rescue of cks1 Disruption
62.2 AÊ , b 5 70.1 AÊ , and c 5 102.4 AÊ and contain one CDK2±CksHs1The ability of the mutant ckshs1 alleles to function in vivo was tested
complex in the asymmetric unit. A 2.8 AÊ resolution diffraction datain a yeast strain that has the chromosomal cks1 gene disrupted and
set, which consisted of 93,477observations for 10,699 unique reflec-is kept alive with a plasmid containing a wild-type copy of CKS1,
tions (93% complete, Rsym 5 8.9%), was collected on form A crystalscks1::LEU2 (CEN TRP1 CKS1) (Richardson et al., 1990). Haploid
using a Fuji plate detector at the 1-5 beamline of the Stanford Syn-cells were transformed with the inducible vector YCpG2 containing
chrotron Radiation Laboratory. Form B crystals belong to the mono-the specific ckshs1 mutant under the control of the GAL1 promoter
clinic space group P21 with cell dimensions a 5 56.8 AÊ , b 5 69.9 AÊ ,and carrying the URA3 gene. Transformants were selected based
c 5 60.5 AÊ , and b 5 114.58 and also contain one CDK2±CksHs1on tryptophan and uracil prototrophy and were switched to growth
complex in the asymmetric unit. A 2.6 AÊ resolution data set, whichfor several generations on medium containing galactose (to allow
consisted of 84,909 observations for 13,023 unique reflections (97%expression of the mutant ckshs1 alleles from the GAL1 promoter)
complete, Rsym 5 10%), was collected on form B crystals using aand tryptophan (to allow loss of the wild-type CKS1 gene and the
Mar-Research imaging plate detector mounted on a Siemens rotat-TRP1 marker). Loss of the plasmid containing the wild-type CKS1
ing anode operating at 50 kV 3 100 mA. Both diffraction data setsgene was monitored by plating and testing colonies for tryptophan
were collected at 21708C, and the crystals were previously trans-auxotrophy.
ferred to 18% MEPEK 5K, 15% ethylene glycol, and 100 mM Tris
(pH 7.5) before being flash cooled. Data sets were processed withBinding Affinity Measurements
the programs DENZO and SCALEPACK (Otwinowski, 1993).Experiments were performed using surface plasmon resonance
technology on a BioSensor BIAcore instrument (Pharmacia). Purified
CksHs1 wild-type and mutant proteins were coupled through pri- Structure Determination and Refinement
mary amine groups to the activated carboxyl groups of CM5 sensor Initial phases for the form A data set were obtained by the molecular
chips according to the procedures of the manufacturer. The matrix replacement method using the human CDK2 model (deBondt et al.,
surface was activated with a mixture of 50 mM N-hydroxysuccini- 1993) and the CksHs1 model (Arvai et al., 1995a) as search models
mide (NHS) and 200 mM N-ethyl-N9-(3-diethylaminopropyl)-carbodi- with the AMoRe program package (Navaza, 1994). Phases from the
imide (EDC) for 7 min at a flow rate of 5 ml/min. Wild-type or mutant positioned CDK2 molecule (correlation 5 37%, R factor 5 46% in
CksHs1 at a concentration of 0.1 mg/ml in 10 mM N-2-hydroxyethyl- the 15 AÊ ±3.5 AÊ resolution range) allowed the positioning of CksHs1
piperazine-N9-2-ethanesulfonic acid (HEPES) (pH 7.4) and 3.4 mM within the cell, giving a final correlation and an R factor of 43%
ethylenediaminetetraacetic (EDTA) was injected over the matrix for for the two molecules. However, refinement of this model with the
7 min at 5 ml/min. Deactivation of the matrix was achieved with 1 X-PLOR program (BruÈnger et al., 1987) resulted in both high R factor
M ethanolamine hydrochloride (pH 8.5) for 7 min at 5 ml/min. The (25%±27%) and R-free (43%±45%) values, associated with poorly
immobilization yield of the protein was monitored from the increase defined electron density maps. The space group was then reexam-
in resonance units during the coupling procedure. After each binding ined, based on the presence of a 2-fold axis along the a axis, but
experiment, the surface of the sensor chip was regenerated by refinement in the space group P21212 (a 5 70.1 AÊ , b 5 102.4 AÊ , and
washing with 50% ethylene glycol, 0.5 M NaCl (pH 7.4) (Kusubata c 5 62.2 AÊ ) resulted in the same problem, and thus suggested the
et al., 1992). Binding sensorgrams for the interaction of CksHs1 presence of twin crystals.
wild-type and mutant proteins were created using concentrations The structure of form B was determined by the molecular replace-
of CDK2 ranging from 5 nM to 5 mM in 10 mM HEPES pH (7.4), ment method with the AMoRe program, using either the solution
3.4 mM EDTA, 150 mM NaCl, and 0.001% surfactant P-20. The from model A or the original coordinates. In both cases, a clear
sensorgrams were analyzed using the BIAevaluation software. Asso- solution was detected with a correlation of 54% and an R factor of
ciation (kon) and dissociation (koff) rate constants were calculated 40% in the 15 AÊ ±3.5 AÊ resolution range. This model was first refined
using the association and dissociation phases of the sensorgrams, by rigid-body motion with the CDK2 N-lobe (residues 1±80), the
respectively. The Kd values were calculated using the equation CDK2 C-lobe (residues 87±296), and the entire CksHs1 (residues
Kd 5 koff/kon. All kinetic experiments were done in triplicate. 5±72) as separate groups, followed by simulated annealing using
X-PLOR and manual fitting into sA-weighting electron density maps
(Read, 1986) with the graphics program TURBO-FRODO (RousselProtein Purification, Crystallization, and X-Ray
Diffraction Data Collection and Cambillau, 1989). Successive rounds of rebuilding and simu-
lated annealing refinements provided electron density maps thatHuman CDK2 was expressed in insect cells (T.ni cells) using a bacu-
lovirus vector. The cells were lysed and centrifuged, and the clarified allowed complete interpretationof both the CDK2 and CksHs1 struc-
tures. X-PLOR omit maps from the final model were used to checksupernatant was directly loaded onto an HS column (Poros) equili-
brated with buffer A (25 mM HEPES [pH 7.4], 25 mM NaCl, 1 mM every part of CDK2 and CksHs1 molecules systematically: ten and
five residues of the structures of CDK2 and CksHs1, respectively,EDTA) and a cocktail of protease inhibitors. CDK2 was eluted with
100 mM NaCl in the same buffer and concentrated before loading were deleted in each calculation, and simulated annealing was used
to reduce model bias in omit maps. The final model (model B, de-onto a S-75 Superdex column equilibrated with buffer B (20 mM
HEPES [pH 7.4], 200 mM NaCl, 1 mM dithiothreitol [DTT]). The same scribed here), which matches the interface defined for crystal form
A above, has an R factor of 19.8% for 11,938 reflections (all data)batch of CksHs1 protein, which was prepared for the crystallization
of free CksHs1, was used in this study (Arvai et al., 1995b). The between 6 AÊ and 2.6 AÊ resolution and a free R factor of 29% (5%
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of the reflections). This model comprises CDK2 residues Met-1 to D.O., and Kim, S.-H. (1993). Crystal structure of cyclin-dependent
kinases 2. Nature 363, 595±602.Thr-39 and Thr-47 to Pro-294 and CksHs1 residues Gln-5 to Pro-
74, with overall deviations from ideal geometry of 0.008 AÊ for bond Ducommun, B., Brambilla, P., and Draetta, G. (1991). Mutations at
distances and 1.58 for bond angles. sites involved in suc1 binding inactivate cdc2. Mol. Cell. Biol. 11,
Because ATP and MnCl2 interfere with the crystallization of the 6177±6184.
complex, the CDK2 catalytic active site is free and filled by solvent
Dunphy, W.G. (1994). The decision to enter mitosis. Trends Cell Biol.molecules. Of these, four are similarly positioned to the N1 and N7
4, 202±207.atoms of the adenosine base, the O92 atom of the ribose, and the
Dunphy, W.G., and Newport, J.W. (1989). Fission yeast p13 blocksg-phosphate group of the ATP molecule bound to CDK2 (deBondt
mitotic activation and tyrosine dephosphorylation of the Xenopuset al., 1993). Within the active site cleft, only the Phe-80 side chain
cdc2 protein kinase. Cell 58, 181±191.flips conformation to interact with the Ala-31 side chain, compared
with its homolog in the ATP-bound CDK2 structure. Temperature Durfee, T., Becherer, K., Chen, P.-L., Yeh, S.-H., Yang, Y., Kilburn,
factors average 24 AÊ 2 for CDK2 main chain (N-lobe, 29 AÊ 2; C-lobe, A.E., Lee, W.-H., and Elledge, S.J. (1993). The retinoblastoma protein
22 AÊ 2), 28 AÊ 2 for CksHs1 main chain, 26 AÊ 2 for CDK2 side chain associates with the protein phosphatase type 1 catalytic subunit.
(N-lobe, 32 AÊ 2; C-lobe, 24 AÊ 2), 31 AÊ 2 for CksHs1 side chain, and 28 Genes Dev. 7, 555±569.
AÊ 2 for 133 solvent molecules. High temperature factors and weak Elble R. (1992). A simple and efficient procedure for transformation
electron density occur for the CDK2 T loop (residues 152±163). of yeasts. Biotechniques 13, 18±20.
The stereochemistry of the model was analyzed with PROCHECK
Endicott, J.A., and Nurse, P. (1995). The cell cycle and suc1: from(Laskowski et al., 1993), and 87% of the polypeptide backbone
structure to function? Structure 3, 321±325.dihedral angles were found to lie in the most favored regions of the
Ramachandran diagram, with the remainder in allowed regions. The Endicott, J.A., Noble, M.E., Garman, E.F., Brown, N., Rasmussen,
B., Nurse, P., and Johnson L.N. (1995). The crystal structure ofcoordinates of model B will be deposited with the Brookhaven Pro-
tein Data Bank. p13suc1, a p34cdc2-interacting cell cycle control protein. EMBO J. 14,
1004±1014.
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